11.63
Delcath Systems Inc stock is traded at $11.63, with a volume of 315.10K.
It is up +0.69% in the last 24 hours and down -11.83% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$11.55
Open:
$11.53
24h Volume:
315.10K
Relative Volume:
0.71
Market Cap:
$387.48M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-4.1241
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
+10.45%
1M Performance:
-11.83%
6M Performance:
+13.69%
1Y Performance:
+159.89%
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DCTH
Delcath Systems Inc
|
11.63 | 387.48M | 2.07M | -47.68M | -31.31M | -2.82 |
![]()
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-28-24 | Initiated | Craig Hallum | Buy |
May-14-24 | Initiated | Stephens | Overweight |
Jul-26-22 | Resumed | Canaccord Genuity | Buy |
Dec-10-21 | Initiated | H.C. Wainwright | Buy |
Mar-09-21 | Initiated | Canaccord Genuity | Buy |
Jan-05-21 | Initiated | BTIG Research | Buy |
Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Delcath Systems Announces Publication of Comparative Analysis fr - GuruFocus
Clinical Data: Delcath's Melanoma Treatment Achieves 175% Better Survival Than Standard Care - Stock Titan
How To Trade (DCTH) - news.stocktradersdaily.com
Pheochromocytoma Treatment Market Size in 7MM is expected - openPR.com
Hospitals Experience FOMO In Adopting Delcath’s PHP Treatment (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems, Inc. (NASDAQ:DCTH) Is Expected To Breakeven In The Near Future - simplywall.st
Charles Schwab Investment Management Inc. Invests $156,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP - Defense World
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN
Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard
Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - Stock Titan
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia
Delcath Systems awards stock options to new employees - Investing.com India
Delcath Systems Strengthens Workforce: 264,000 Stock Options Granted to New Strategic Hires - StockTitan
Delcath Systems Reports Strong 2024 Financial Growth - TipRanks
With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St
Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks
HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks
Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India
Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks
Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance
Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... - Yahoo Finance
Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes - TipRanks
BTIG lifts Delcath Systems stock target to $22, maintains buy By Investing.com - Investing.com Canada
BTIG lifts Delcath Systems stock target to $22, maintains buy - Investing.com
Delcath Systems reports Q4 EPS (11c), consensus 1c - TipRanks
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):